Cargando…
The use of the rapid osmotic fragility test as an additional test to diagnose canine immune-mediated haemolytic anaemia
BACKGROUND: Diagnosing canine immune-mediated haemolytic anaemia (IMHA) is often challenging because all currently available tests have their limitations. Dogs with IMHA often have an increased erythrocyte osmotic fragility (OF), a characteristic that is sometimes used in the diagnosis of IMHA. Sinc...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816578/ https://www.ncbi.nlm.nih.gov/pubmed/24160183 http://dx.doi.org/10.1186/1751-0147-55-74 |
_version_ | 1782477957110956032 |
---|---|
author | Paes, Geert Paepe, Dominique Meyer, Evelyne Kristensen, Annemarie T Duchateau, Luc Campos, Miguel Daminet, Sylvie |
author_facet | Paes, Geert Paepe, Dominique Meyer, Evelyne Kristensen, Annemarie T Duchateau, Luc Campos, Miguel Daminet, Sylvie |
author_sort | Paes, Geert |
collection | PubMed |
description | BACKGROUND: Diagnosing canine immune-mediated haemolytic anaemia (IMHA) is often challenging because all currently available tests have their limitations. Dogs with IMHA often have an increased erythrocyte osmotic fragility (OF), a characteristic that is sometimes used in the diagnosis of IMHA. Since the classic osmotic fragility test (COFT) is time-consuming and requires specialized equipment, an easy and less labour-intensive rapid osmotic fragility test (ROFT) has been used in some countries, but its diagnostic value has not yet been investigated. This study aimed to evaluate erythrocyte osmotic fragility in dogs with and without IMHA, to compare results of the classic (COFT) and rapid (ROFT) test and to assess the value of the ROFT as diagnostic test for canine IMHA. Nineteen dogs with IMHA (group 1a), 21 anaemic dogs without IMHA (group 1b), 8 dogs with microcytosis (group 2), 13 hyperlipemic dogs (group 3), 10 dogs with lymphoma (group 4), 8 dogs with an infection (group 5) and 13 healthy dogs (group 6) were included. In all dogs, blood smear examination, in-saline auto-agglutination test, Coombs’ test, COFT and ROFT were performed. In the COFT, OF5, OF50 and OF90 were defined as the NaCl concentrations at which respectively 5, 50 and 90% of erythrocytes were haemolysed. RESULTS: Compared with healthy dogs, OF5 and OF50 were significantly higher in group 1a (P < 0.001) and OF5 was significantly higher in group 3 (P = 0.0266). The ROFT was positive in 17 dogs with IMHA, 10 hyperlipemic dogs, one anaemic dog without IMHA and one healthy dog. CONCLUSIONS: Osmotic fragility was increased in the majority of dogs with IMHA and in dogs with hyperlipidemia, but not in dogs with microcytosis, lymphoma or an infection. Although more detailed information was obtained about the osmotic fragility by using the COFT, the COFT and ROFT gave similar results. The ROFT does not require specialized equipment, is rapid and easy to perform and can be used easily in daily practice. Although, the ROFT cannot replace other diagnostic tests, it may be a valuable additional tool to diagnose canine IMHA. |
format | Online Article Text |
id | pubmed-3816578 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-38165782013-11-05 The use of the rapid osmotic fragility test as an additional test to diagnose canine immune-mediated haemolytic anaemia Paes, Geert Paepe, Dominique Meyer, Evelyne Kristensen, Annemarie T Duchateau, Luc Campos, Miguel Daminet, Sylvie Acta Vet Scand Research BACKGROUND: Diagnosing canine immune-mediated haemolytic anaemia (IMHA) is often challenging because all currently available tests have their limitations. Dogs with IMHA often have an increased erythrocyte osmotic fragility (OF), a characteristic that is sometimes used in the diagnosis of IMHA. Since the classic osmotic fragility test (COFT) is time-consuming and requires specialized equipment, an easy and less labour-intensive rapid osmotic fragility test (ROFT) has been used in some countries, but its diagnostic value has not yet been investigated. This study aimed to evaluate erythrocyte osmotic fragility in dogs with and without IMHA, to compare results of the classic (COFT) and rapid (ROFT) test and to assess the value of the ROFT as diagnostic test for canine IMHA. Nineteen dogs with IMHA (group 1a), 21 anaemic dogs without IMHA (group 1b), 8 dogs with microcytosis (group 2), 13 hyperlipemic dogs (group 3), 10 dogs with lymphoma (group 4), 8 dogs with an infection (group 5) and 13 healthy dogs (group 6) were included. In all dogs, blood smear examination, in-saline auto-agglutination test, Coombs’ test, COFT and ROFT were performed. In the COFT, OF5, OF50 and OF90 were defined as the NaCl concentrations at which respectively 5, 50 and 90% of erythrocytes were haemolysed. RESULTS: Compared with healthy dogs, OF5 and OF50 were significantly higher in group 1a (P < 0.001) and OF5 was significantly higher in group 3 (P = 0.0266). The ROFT was positive in 17 dogs with IMHA, 10 hyperlipemic dogs, one anaemic dog without IMHA and one healthy dog. CONCLUSIONS: Osmotic fragility was increased in the majority of dogs with IMHA and in dogs with hyperlipidemia, but not in dogs with microcytosis, lymphoma or an infection. Although more detailed information was obtained about the osmotic fragility by using the COFT, the COFT and ROFT gave similar results. The ROFT does not require specialized equipment, is rapid and easy to perform and can be used easily in daily practice. Although, the ROFT cannot replace other diagnostic tests, it may be a valuable additional tool to diagnose canine IMHA. BioMed Central 2013-10-25 /pmc/articles/PMC3816578/ /pubmed/24160183 http://dx.doi.org/10.1186/1751-0147-55-74 Text en Copyright © 2013 Paes et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Paes, Geert Paepe, Dominique Meyer, Evelyne Kristensen, Annemarie T Duchateau, Luc Campos, Miguel Daminet, Sylvie The use of the rapid osmotic fragility test as an additional test to diagnose canine immune-mediated haemolytic anaemia |
title | The use of the rapid osmotic fragility test as an additional test to diagnose canine immune-mediated haemolytic anaemia |
title_full | The use of the rapid osmotic fragility test as an additional test to diagnose canine immune-mediated haemolytic anaemia |
title_fullStr | The use of the rapid osmotic fragility test as an additional test to diagnose canine immune-mediated haemolytic anaemia |
title_full_unstemmed | The use of the rapid osmotic fragility test as an additional test to diagnose canine immune-mediated haemolytic anaemia |
title_short | The use of the rapid osmotic fragility test as an additional test to diagnose canine immune-mediated haemolytic anaemia |
title_sort | use of the rapid osmotic fragility test as an additional test to diagnose canine immune-mediated haemolytic anaemia |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816578/ https://www.ncbi.nlm.nih.gov/pubmed/24160183 http://dx.doi.org/10.1186/1751-0147-55-74 |
work_keys_str_mv | AT paesgeert theuseoftherapidosmoticfragilitytestasanadditionaltesttodiagnosecanineimmunemediatedhaemolyticanaemia AT paepedominique theuseoftherapidosmoticfragilitytestasanadditionaltesttodiagnosecanineimmunemediatedhaemolyticanaemia AT meyerevelyne theuseoftherapidosmoticfragilitytestasanadditionaltesttodiagnosecanineimmunemediatedhaemolyticanaemia AT kristensenannemariet theuseoftherapidosmoticfragilitytestasanadditionaltesttodiagnosecanineimmunemediatedhaemolyticanaemia AT duchateauluc theuseoftherapidosmoticfragilitytestasanadditionaltesttodiagnosecanineimmunemediatedhaemolyticanaemia AT camposmiguel theuseoftherapidosmoticfragilitytestasanadditionaltesttodiagnosecanineimmunemediatedhaemolyticanaemia AT daminetsylvie theuseoftherapidosmoticfragilitytestasanadditionaltesttodiagnosecanineimmunemediatedhaemolyticanaemia AT paesgeert useoftherapidosmoticfragilitytestasanadditionaltesttodiagnosecanineimmunemediatedhaemolyticanaemia AT paepedominique useoftherapidosmoticfragilitytestasanadditionaltesttodiagnosecanineimmunemediatedhaemolyticanaemia AT meyerevelyne useoftherapidosmoticfragilitytestasanadditionaltesttodiagnosecanineimmunemediatedhaemolyticanaemia AT kristensenannemariet useoftherapidosmoticfragilitytestasanadditionaltesttodiagnosecanineimmunemediatedhaemolyticanaemia AT duchateauluc useoftherapidosmoticfragilitytestasanadditionaltesttodiagnosecanineimmunemediatedhaemolyticanaemia AT camposmiguel useoftherapidosmoticfragilitytestasanadditionaltesttodiagnosecanineimmunemediatedhaemolyticanaemia AT daminetsylvie useoftherapidosmoticfragilitytestasanadditionaltesttodiagnosecanineimmunemediatedhaemolyticanaemia |